Finally, we demonstrated that blocking IL-17 signaling by IL-17 neutralization during CRC could ameliorate the enhanced CRC severity we observed in IEC-miR-146a−/− mice (Fig. 4x, y) and global miR-146a−/− mice (Supplementary Fig. 4p, q). Here, IL17A is linked to colorectal carcinoma.